| HepG2 | 
Caption: IP-Western Blot analysis of HepG2 whole cell lysate using TRA2A specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 10% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-TRA2A antibody (lanes under 'TRA2A'). Method: immunoprecipitation Releated Sample: eCLIP:218 Status: Released Lab: Yeo Lab | 
Caption: Western blot following shRNA against TRA2A in HepG2 whole cell lysate using TRA2A specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against TRA2A. TRA2A protein appears as the green band, Tubulin serves as a control and appears in red. Releated Sample: BGHLV14-61 Status: Released Lab: Graveley Lab |
|---|
| K562 | 
Caption: IP-Western Blot analysis of K562 whole cell lysate using TRA2A specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-TRA2A antibody (lanes under 'TRA2A'). Method: immunoprecipitation Releated Sample: eCLIP:240 Status: Released Lab: Yeo Lab | 
Caption: Western blot following CRISPR against TRA2A in K562 whole cell lysate using TRA2A specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against TRA2A. TRA2A protein appears as the green band, Tubulin serves as a control and appears in red. Releated Sample: BGKcLV11-105 Status: Released Lab: Graveley Lab |
|---|